A very recent paper even reported that CT treatment of prostate cancer stem cells could inhibit their proliferation and tumorigenesis by downregulating the expression of stemness genes including Nanog, SOX2, Oct4, and CXCR4 [44]. This evidence concerns the gene NANOG and prostate carcinoma.